EMB-06

· Shanghai EpimAb Biotherapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EMB-06, covering 2025-05-28 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma [Phase 1, Phase 2]